Research Paper Volume 15, Issue 22 pp 13329—13344

circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis

class="figure-viewer-img"

Figure 2. Overexpression of circSLCO1B7 inhibited the progression of HCC cells. (A) qRT–PCR analysis of the expression of circSLCO1B7 in HCC cells. (B) The CCK-8 assay was used to detect the proliferation ability of transfected SK-HEP-1 and PLC/PRF/5 cells. (C) The migration and invasion abilities of transfected SK-HEP-1 and PLC/PRF/5 cells were measured by Transwell assay. (D) A wound healing assay was performed to detect the migration levels of transfected SK-HEP-1 and PLC/PRF/5 cells. (E, F) After overexpression in SK-HEP-1 and PLC/PRF/5 cells, the apoptosis rate (E) and distribution of the cell cycle (F) were analysed by flow cytometry and compared to the vector group. All data are presented as the means ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.